No Data
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System
Accelerate Diagnostics Announces FDA Clearance Of Its Accelerate Arc System, An Automated Platform Designed To Fight Against Sepsis And Antimicrobial Resistance
Express News | Accelerate Diagnostics Announces FDA Clearance of Its Accelerate ARC™ System
Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial
Earnings Call: Accelerate Diagnostics Q2 2024 Results and Wave Program Update
Earnings Call Summary | Accelerate Diagnostics(AXDX.US) Q2 2024 Earnings Conference